Pure Global AI
NCT06331754Not yet recruiting

Technology-Enabled Remote Hypertension Management To Advance Health Equity

Atman Health, IncClinicalTrials.govother
Verified
Study focus
Disease/Condition
Hypertension
Drug/Device/Intervention
Technology-enabled blood pressure management
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Atman Health, Inc
Timeline & enrollment
Phase
N/A
Start date
Mar 18, 2024
End date
Mar 17, 2026
Enrollment
1500 participants
Primary outcome

Difference in SBP change

Summary

The primary objective of this study is to reliably estimate the difference in blood pressure
 control of a technology-enabled solution for blood pressure (BP) management over usual care.
 The study will also assess patient and provider satisfaction with the solution. Finally, the
 investigators will estimate the economic impact of the intervention in terms of resource
 utilization.

ICD-10 classifications
Hypertensive diseasesRenovascular hypertensionSecondary hypertensionOther secondary hypertensionHypertensive heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06331754
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06331754 through Pure Global AI's free database. This phase not specified trial is sponsored by Atman Health, Inc and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 1500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.